Supplemental Table 1 Cohort of parous and nulliparous women and other

Supplemental Table 1 Cohort of parous and nulliparous women and other parameters. Detailed description of the subjects, included in the pyrosequencing study, with regards to their parity status (top 19: parous, Bottom 16: Nulliparous), Menopausal status, BMI, Ethnicity, and diseased status (Type II diabetes and cardio vascular disease) (Black: Parous, Red: Nulliparous)

Supplemental Table 3. Methylation pattern of position 2 and 18 of FOXA1 in relation to parameters other than parity: Menopausal status, BMI, Type II diabetes, Cardio vascular disease and Ethnicity. (Similar procedure, as depicted in fig 2 was, followed to measure % methylation for each position)

Supplemental Table 1 Cohort of parous and nulliparous women and other

Supplemental Table 1 Cohort of parous and nulliparous women and other

Presentation Transcript

Cohort 1

The Dystocia Epidemic in Nulliparous Women

Supplemental Table : Information of primers

Supplemental Table 1 .

Supplemental Table 1

Supplemental Table S1

Supplemental Table 1

Supplemental Table 1. Effects of celecoxib on cardiac function.

Footnotes – Supplemental Table S3

Supplemental Table 2

Supplemental File 1, Table 1s

Supplemental Table 5

Supplemental Table S1

Supplemental Table 1: Receptor Status

Online Supplemental Table

Study of IUD insertions and clinical performance in nulliparous women

Supplemental table 1

Supplemental table 2

Supplemental Table 1. Sequences of primers and probes

Supplemental Table 1

Supplemental Table S1

Supplemental Table S1. (Continued)